SciBase receives US patent for Nevisense electrode design

May 2nd SciBase received patent approval for a further US patent.On May 2nd 2017 SciBase received confirmation that US patent number 9,636,035 has been approved. The patent protects the unique shape of the microneedles that enable detection of malignant melanoma in the skin using electrical impedance as demonstrated with high precision in clinical trials. In total SciBase now has 3 patent families approved in the US and an additional family in process. ”Our electrode design is one of the key reasons for the success of our method. It is positive that we further strengthen our patent